Long COVID Trial, Recruiting NCT06928506 Sponsor: University Health Network, Toronto Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT06928506
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You either had a confirmed positive COVID-19 test (by swab, antibody, or antigen test) at least 3 months before joining, OR you had an illness consistent with COVID-19 after October 15, 2019, even without a positive test (confirm with trial site)
  • You have been receiving standard treatments for your Long COVID symptoms for at least 4 weeks before joining
  • Your COVID-19 symptoms have continued for more than 3 months since you first got sick, and have lasted at least 2 months
  • You are still experiencing lingering COVID-19 symptoms at the time of joining, and these must include self-reported problems with thinking, memory, or mental clarity (sometimes called "brain fog")
  • If you are a woman who could become pregnant and are sexually active, you must agree to use effective birth control or abstain from sex during the study (as approved by the study doctor)
  • You are able to understand and sign a consent form and are willing and able to follow the study requirements
  • Your blood oxygen level is 92% or higher when measured at your screening visit

Who may not be able to join:

  • You required a breathing machine (ventilator) or a heart-lung bypass machine (ECMO) during your COVID-19 illness
  • You currently have organ failure, have had an organ transplant, or are currently admitted to a hospital
  • You have medical reasons that prevent you from taking any of the study treatments (confirm with trial site)
  • You are currently taking part in another clinical trial that involves a treatment or intervention
  • You are currently pregnant or breastfeeding
  • You were diagnosed by a doctor with memory or thinking problems before you had COVID-19
  • You have used an experimental drug or device within the past 30 days before your screening visit
  • You currently use supplemental oxygen at home
  • You have a history of high blood pressure in the lungs (pulmonary hypertension)
  • You have a lung condition involving scarring of lung tissue (interstitial pulmonary fibrosis)
  • You have moderate to severe chronic obstructive pulmonary disease (COPD)
  • You have a history of narcolepsy (a sleep disorder causing sudden episodes of sleep)
  • You have any other condition that the study doctor believes could put your safety at risk or affect the reliability of the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela M Cheung, MD, PhD, University Health Network, Toronto

Phone: 1-866-673-2524

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Simple reaction time (SRT) task from the TestMyBrain (TMB) Digital Neuropsychology Toolkit On-line survey tool; Verbal paired associates (VPA) task from the TestMyBrain (TMB) Digital Neuropsychology Toolkit On-line survey tool

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov